Ad is loading...
MENU

EQ Equillium Forecast, Technical & Fundamental Analysis

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology
EQ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
EQ
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EQ is expected to report earnings to fall ∞% to -28 cents per share on March 26

Equillium EQ Stock Earnings Reports
Q4'24
Est.
$-0.28
Q3'24
Missed
by $0.02
Q2'24
Beat
by $0.16
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.10
The last earnings report on November 13 showed earnings per share of 0 cents, missing the estimate of 1 cents. With 127.34K shares outstanding, the current market capitalization sits at 25.14M.
A.I. Advisor
published General Information

General Information

a developer of products for severe immune-inflammatory disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2223 Avenida De La Playa
Phone
+1 858 240-1200
Employees
44
Web
https://www.equilliumbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EIX83.681.55
+1.89%
Edison International
APLE15.50-0.09
-0.58%
Apple Hospitality REIT
DOYU10.41-0.12
-1.19%
DouYu International Holdings Limited
BZH33.30-1.33
-3.84%
Beazer Homes USA
OCX2.61-0.19
-6.79%
Oncocyte Corp

EQ and Stocks

Correlation & Price change

A.I.dvisor tells us that EQ and MTNB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EQ and MTNB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EQ
1D Price
Change %
EQ100%
+3.71%
MTNB - EQ
32%
Poorly correlated
-2.27%
IMNM - EQ
32%
Poorly correlated
-11.09%
AUTL - EQ
27%
Poorly correlated
+2.33%
BLRX - EQ
24%
Poorly correlated
+3.83%
CMPX - EQ
24%
Poorly correlated
-13.21%
More